Skip to main content

Table 1 Patients demographics

From: Amelioration of fatigue in chronic dialysis patients with dialysis solution employing electrolyzed water containing molecular hydrogen (H2) and its association with autonomic function balance

  Group-A HD-responsive type Group-B chronic type Group-C fatigue-free type P
N 38 (40.0%) 11 (11.6%) 46 (48.4%)  
Age (years) 71.2 ± 8.8 66.9 ± 11.4 72.7 ± 9.8 NS
Male (%) 19 (50.0%) 5 (45.5%) 30 (65.2%) NS
HD vintage (years) 11.4 ± 10.1 19.4 ± 12.6 7.8 ± 7.8 0.001
A versus C: 0.001
B versus C: 0.045
Modality (HD/OLHDF) 22/16 9/2 31/15 NS
Presence of DM 9 (23.7%) 2 (18.2%) 18 (39.1%) NS
Body weight (kg) 54.8 ± 13.8 50.4 ± 11.5 55.3 ± 10.8 NS
SBP and DBP (mmHg) before HD 137 ± 20 142 ± 38 141 ± 25 NS
73 ± 13 75 ± 19 76 ± 16 NS
UF volume/session (kg) 2.6 ± 0.8 2.0 ± 0.8 2.3 ± 0.8 NS
History CVD 5 (13.2%) 4 (36.4%) 10 (21.7%)  
Creatinine (mg/dL) 9.5 ± 2.0 8.6 ± 1.5 9.6 ± 2.2 NS
Hemoglobin (g/dL) 11.1 ± 1.2 11.4 ± 0.7 11.3 ± 1.2 NS
Albumin (g/dL) 3.41 ± 0.26 3.25 ± 0.34 3.42 ± 0.32 NS
  1. HD hemodialysis, OLHDF online hemodiafiltration, DM diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, UF ultrafiltration, NS not significant